Study of CP-675,206 in Refractory Melanoma

Clinical trial NCT00254579 · COMPLETED

Trial details

NCT number: NCT00254579
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Refractory Melanoma

Start date: 2005-12-01
Primary completion: 2009-12-01
Enrollment: 251

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.